Is ARX/PDX1 Expression Profile Associated with Adverse Histopathologic Features Including Venous Invasion in Non-Functional Pancreatic Neuroendocrine Tumors
Publication
, Conference
Chen, W; Revetta, F; Shi, C
Published in: LABORATORY INVESTIGATION
2024
Duke Scholars
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
2024
Volume
104
Issue
3
Start / End Page
S1819 / S1821
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Chen, W., Revetta, F., & Shi, C. (2024). Is ARX/PDX1 Expression Profile Associated with Adverse Histopathologic Features Including Venous Invasion in Non-Functional Pancreatic Neuroendocrine Tumors. In LABORATORY INVESTIGATION (Vol. 104, pp. S1819–S1821).
Chen, Wei, Frank Revetta, and Chanjuan Shi. “Is ARX/PDX1 Expression Profile Associated with Adverse Histopathologic Features Including Venous Invasion in Non-Functional Pancreatic Neuroendocrine Tumors.” In LABORATORY INVESTIGATION, 104:S1819–21, 2024.
Chen W, Revetta F, Shi C. Is ARX/PDX1 Expression Profile Associated with Adverse Histopathologic Features Including Venous Invasion in Non-Functional Pancreatic Neuroendocrine Tumors. In: LABORATORY INVESTIGATION. 2024. p. S1819–21.
Chen, Wei, et al. “Is ARX/PDX1 Expression Profile Associated with Adverse Histopathologic Features Including Venous Invasion in Non-Functional Pancreatic Neuroendocrine Tumors.” LABORATORY INVESTIGATION, vol. 104, no. 3, 2024, pp. S1819–21.
Chen W, Revetta F, Shi C. Is ARX/PDX1 Expression Profile Associated with Adverse Histopathologic Features Including Venous Invasion in Non-Functional Pancreatic Neuroendocrine Tumors. LABORATORY INVESTIGATION. 2024. p. S1819–S1821.
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
2024
Volume
104
Issue
3
Start / End Page
S1819 / S1821
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences